[6-K] NatWest Group plc American Current Report (Foreign Issuer)
Rhea-AI Filing Summary
NatWest Group plc executed a share repurchase on 14 August 2025, buying 1,925,520 ordinary shares from Merrill Lynch International (BofA) on the London Stock Exchange. The trades recorded a highest price of 555.20p, a lowest price of 542.60p and a volume-weighted average price of 552.55p. The repurchase was carried out under the Company’s existing buyback programme instructed to BofA on 25 July 2025 and announced on 28 July 2025. The Company intends to cancel the repurchased shares. After settlement the Company will hold 231,229,355 treasury shares and have 8,080,095,287 shares in issue excluding treasury.
Positive
- Repurchase completed under an existing, authorized buyback programme
- Company intends to cancel the repurchased shares, which will reduce issued share count excluding treasury
Negative
- None.
Insights
TL;DR: Routine execution of an announced buyback: 1.93m shares repurchased at a VWAP of 552.55p; intended cancellation limits immediate dilution.
This transaction is a scheduled tranche under the existing buyback programme instructed on 25 July 2025 and announced 28 July 2025. The filing reports trade-level price range (555.20p high, 542.60p low) and a VWAP of 552.55p, executed on the LSE and purchased from Merrill Lynch International. The Company states the repurchased shares will be cancelled and provides updated treasury and issued share figures. Impact assessment: neutral given routine nature and explicit programme context.
TL;DR: Share buyback executed under an existing mandate with cancellation planned; maintains capital-return policy consistency.
The Form 6-K confirms that the repurchase was effected under instructions to BofA and that the Company intends to cancel the repurchased Ordinary Shares, which is a governance-level decision affecting issued share capital. The disclosure includes post-settlement treasury holdings and issued share count excluding treasury, and references a detailed trade breakdown in an attached RNS. The filing follows market disclosure requirements and supplies the Legal Entity Identifier. Impact assessment: not materially disruptive to governance structures.